Encompass Health Corporation (EHC)

Encompass Health Corporation demonstrates robust fundamental economics, characterized by a significant ROIC-WACC spread of +6.1%, indicating strong value creation relative to the cost of capital. The DuPont decomposition reveals that this return is primarily driven by exceptional efficiency and profitability rather than leverage; specifically, the company boasts an industry-leading 95.7% gross margin alongside healthy net margins at 9.5%. These operational strengths are corroborated by pristine integrity metrics: a perfect Piotroski F-Score of 9/9 signals improving financial health across nine dimensions, while a Beneish M-Score of -4.97 effectively rules out earnings manipulation. Furthermore, an Altman Z-Score of 3.1 places the firm firmly in the safe zone for bankruptcy risk, suggesting high operational stability despite its capital-intensive healthcare model.

Valuation analysis presents a distinct divergence between current market pricing and intrinsic value models. The stock trades at a P/E ratio of 17.4x, which is substantially compressed relative to the sector average of 37.0x, implying the market may be applying a discount due to specific macro or structural concerns rather than fundamental deterioration. Conversely, discounted cash flow modeling suggests a fair value of $195 per share, hinting that current prices might not fully reflect long-term growth potential if execution remains consistent with historical revenue expansion rates near 10.5% annually. This discrepancy between the low multiple and higher DCF target creates an interesting risk-reward dynamic where downside protection is theoretically offered by the valuation floor, yet upside depends on whether earnings can eventually justify a re-rating toward sector norms.

No additional data regarding Fama-French alpha, insider trading activity, or specific risk factor deltas was provided for this analysis; therefore, the assessment relies solely on the internal consistency of profitability metrics and relative valuations. The convergence of high-quality fundamentals with a depressed multiple suggests the market is pricing in potential headwinds that may not be fully reflected in the underlying cash flow generation capabilities.